Search results
Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar
Zacks via Yahoo News· 9 months agoNovartis’ NVS generic arm Sandoz announced that the European Commission (EC) granted marketing...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo News· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo News· 12 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) Q3 Earnings Top, Revenues Miss Estimates
Zacks via Yahoo News· 2 years agoNovartis AG NVS reported mixed third-quarter results for 2022 and revised its guidance for the...
What's in Store for Novartis (NVS) This Earnings Season?
Zacks via Yahoo News· 2 years agoInvestors will focus on the regular top and bottom-line numbers along with updates on the Sandoz...
Novartis (NVS) to Report Q3 Earnings: What's in the Offing?
Zacks via Yahoo News· 9 months agoInvestor focus is likely to be on the top and bottom-line numbers, and updates on guidance...
Novartis (NVS) to Report Q2 Earnings: Is a Beat in Store?
Zacks via Yahoo News· 12 months agoWhen Novartis (NVS) reports second-quarter 2023 results, investor focus is likely to be on updates...
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Zacks via Yahoo News· 3 months agoThe impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo News· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo News· 3 months agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...